David B Patteson

David B. Patteson is currently President and CEO and member of the Board of Directors of Advion, Inc. a developer and supplier of ion sources and mass spectrometers for life science research. Prior to the sale of their CRO business to Quintiles, Inc. in November 2011, Patteson was also the CEO of Advion BioSciences, the largest North American Bioanalytical Contract Research Organization. Prior to Advion, Mr. Patteson served as CEO of Biotage, Inc., the largest global supplier of systems and consumables for pharmaceutical and biotech synthetic chemists. While at Biotage, Mr. Patteson grew revenues tenfold through a combination of organic means and acquisitions. Prior to Biotage he served as Corporate Vice President and General Manager for Siebe plc’s Field Measurement and Controls Division and was responsible for over $250M of business revenues, 1,200 employees, and oversaw global operations. He is also a member of the Board of Directors of Contravac, Inc., and the Advisory Board for Hemoshear, Inc., both biotechnology companies. He has served on the Boards of Corporate Advisors for Biotechnology, the University of Virginia’s Coulter Foundation for Translational Research, and as a Director on the Board for the University of Virginia Foundation, where he was Chairman of the Finance and Audit Committee. He holds degrees from the University of Richmond and Virginia Polytechnic Institute and completed a two-year, multi-national program in International Management co-managed with the Institute of Management Development (IMD) in Lausanne, Switzerland, and the University of Gothenburg, Sweden.